1050 |
50 mg |
Cerebrosides |
Galactosylceramide, ceramide beta-D-galactoside |
1066 |
10 mg |
Cerebrosides; Kerasin (top spot) |
Galactosylceramide with mostly non-hydroxy fatty acid side chain |
1138 |
10 mg |
Cerebrosides; Phrenosin, (bottom spot) |
Galactosylceramide with mostly 2-hydroxy fatty acid side chains |
1305 |
10 mg |
Psychosine, (free amine form) |
lyso-Cerebroside; 1-beta-D-galactosylsphingosine |
1325 |
10 mg |
N-Acetyl-psychosine |
C2-Cerebroside |
1334 |
10 mg |
N-Octanoyl-beta-D-galactosylceramide |
N-C8:0-Galactosylceramide |
1335 |
5 mg |
N-Pentadecanoyl-psychosine |
N-C15:0-Cerebroside |
1621 |
100 µg |
N-Hexanoyl-NBD-galactosylceramide |
N-C6:0-NBD-beta-D-galactosylsphingosine; N-C6:0-NBD-cerebroside; N-C6:0-NBD-galactosylceramide, fluorescent |
1633 |
100 µg |
N-Dodecanoyl-NBD-galactosylceramide |
N-C12:0-NBD-beta-D-Galactosylsphingosine; N-C12:0-NBD-Cerebrosidee |
1633-001 |
1 mg |
N-Dodecanoyl-NBD-galactosylceramide |
N-C12:0-NBD-beta-D-Galactosylsphingosine; N-C12:0-NBD-Cerebrosidee |
1914 |
5 mg |
N-Octadecanoyl-D35-psychosine, perdeuterated |
Cerebrosides with C18-D35 fatty acid side chain |
1937 |
10 mg |
N-Dodecanoyl-beta-D-galactosylceramide |
N-C12:0-Galactosylceramide; N-Dodecanoyl-beta-D-galactosylsphingosine |
1937-50 |
50 mg |
N-Dodecanoyl-beta-D-galactosylceramide |
N-C12:0-Galactosylceramide; N-Dodecanoyl-beta-D-galactosylsphingosine |
2054 |
500 µg |
N-omega-CD3-Octadecanoyl disialoganglioside GD3 |
N-CD3-Stearoyl GD3 |
2203 |
5 mg |
N-Hexanoyl-biotin-galactosylceramide |
N-C6:0-Biotin-beta-D-galactosylsphingosine; N-C6:0-Biotin-cerebroside |